Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
BeiGene Ltd (HK:6160)
HKEX:6160
Holding HK:6160?
Track your performance easily
6160 Stock Chart & Stats
Day’s RangeHK$0 - HK$0
52-Week RangeHK$75.45 - HK$153.00
Previous CloseHK$104.7
Volume2.05M
Average Volume (3M)2.28M
Market Cap
HK$152.62B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.11
Next Earnings
Mar 26, 2025EPS Estimate
-HK$0.55Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.95
Shares Outstanding1,353,730,830
10 Day Avg. Volume2,380,673
30 Day Avg. Volume2,281,743
Standard Deviation0.13
R-Squared0.14
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)2.64
Price to Sales (P/S)6.26
Price to Cash Flow (P/CF)-9.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$165.86Price Target Upside58.41% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
BeiGene Ltd News
PremiumCompany Announcements
BeiGene’s Latest SEC Filing and Stock Exchange Updates
PremiumCompany Announcements
BeiGene Ltd Announces New Share Options and RSUsOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
2.49% Mutual Funds
― Other Institutional Investors
92.66% Public Companies and
Individual Investors
6160 FAQ
What was BeiGene Ltd’s price range in the past 12 months?
BeiGene Ltd lowest stock price was HK$75.45 and its highest was HK$153.00 in the past 12 months.
What is BeiGene Ltd’s market cap?
Currently, no data Available
When is BeiGene Ltd’s upcoming earnings report date?
BeiGene Ltd’s upcoming earnings report date is Mar 26, 2025 which is in 94 days.
How were BeiGene Ltd’s earnings last quarter?
BeiGene Ltd released its earnings results on Nov 12, 2024. The company reported -HK$0.688 earnings per share for the quarter, missing the consensus estimate of -HK$0.667 by -HK$0.021.
Is BeiGene Ltd overvalued?
According to Wall Street analysts BeiGene Ltd’s price is currently Undervalued.
Does BeiGene Ltd pay dividends?
BeiGene Ltd does not currently pay dividends.
What is BeiGene Ltd’s EPS estimate?
BeiGene Ltd’s EPS estimate is -HK$0.55.
How many shares outstanding does BeiGene Ltd have?
BeiGene Ltd has 1,269,031,700 shares outstanding.
What happened to BeiGene Ltd’s price movement after its last earnings report?
BeiGene Ltd reported an EPS of -HK$0.688 in its last earnings report, missing expectations of -HK$0.667. Following the earnings report the stock price went down -2.716%.
Which hedge fund is a major shareholder of BeiGene Ltd?
Currently, no hedge funds are holding shares in HK:6160
---
BeiGene Ltd Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-4.81%
12-Months-Change
Fundamentals
Return on Equity
-23.94%
Trailing 12-Months
Asset Growth
4.67%
Trailing 12-Months
Company Description
BeiGene Ltd
BeiGene Ltd is a commercial-stage biotechnology company. It is engaged in the discovery and development of molecularly targeted and immuno-oncology drugs for the treatment of cancer. The company has developed a proprietary cancer biology platform that addresses the importance of tumor-immune system interactions and the value of primary biopsies in developing new models to support its drug discovery effort. It has developed clinical-stage drug candidates that inhibit the important oncology targets Bruton's tyrosine kinase, or BTK; RAF dimer protein complex and PARP family of proteins, and an immuno-oncology agent that inhibits the immune checkpoint protein receptor PD-1. Its geographical segments are China, the United States, and the Rest of the world.
---
6160 Stock 12 Month Forecast
Average Price Target
HK$165.86
▲(58.41% Upside)
Technical Analysis
Viva Biotech Holdings
―
Lai Si Enterprise Holding Ltd.
―
Steve Leung Design Group Limited
―
Best Analysts Covering 6160
1 Year
1 Year Success Rate
3/7 ratings generated profit
1 Year Average Return
-11.06%
reiterated a buy rating 2 months ago
Copying Jialin Zhang's trades and holding each position for 1 Year would result in 42.86% of your transactions generating a profit, with an average return of -11.06% per trade.
---